Hepatitis B surface antibodies in medical students from a public university in Puebla, Mexico

References

• Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45:529-38; PMID:16879891; http://dx.doi.org/10.1016/j.jhep.2006.05.013
   PubMed Web of Science ®Google Scholar
• BagheriJ M, Keshavarz J, Nemati M, MohammadiH S, Rezayati MT, Nejad M, Jamalizadeh A, Shokri F, Jafarzadeh A. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Hum Vaccin Immunother 2014; 10:3731-6; PMID:25483689; http://dx.doi.org/10.4161/hv.34393
   PubMed Web of Science ®Google Scholar
• Ganem D, Prince AM. Hepatitis B virus infectionnatural history and clinical consequences. N Engl J Med 2004; 350:1118-29; PMID:15014185; http://dx.doi.org/10.1056/NEJMra031087
   PubMed Web of Science ®Google Scholar
• Chen CC, Yen CH, Wu WY, Hu SW, Chen SC, Bell WR, Lee MC. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program. Chin Med J 2007; 120(13):1155-8; PMID:17637244
   PubMed Web of Science ®Google Scholar
• Su FH, Chen JD, Cheng SH, Sung KY, Jeng JJ, Chu FY. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination program. J Viral Hepatol 2008; 15(1):14-9; PMID:18088240
   PubMed Web of Science ®Google Scholar
• Araujo MW, Andreana S. Risk and prevention of transmission of infectious diseases in dentistry. Quintessence Int 2002; 33(5):376-82; PMID:12014168
   PubMed Web of Science ®Google Scholar
• Sacchetto MS, Barros SS, Araripe TA, Silva AM, Faustino SK, da Silva JM. Hepatitis B: knowledge, vaccine situation and seroconversion of dentistry students of a public university. Hepat Mon 2013; 13(10):e13670; PMID:24348639; http://dx.doi.org/10.5812/hepatmon.13670
   PubMedGoogle Scholar
• Valdespino JL, Conde-González CJ, Olaiz-Fernández G, Palma O, Sepúlveda J. Prevalencia en México de la infección y el estado de portador de la hepatitis B en adultos. Salud Pública Mex 2007; 49 suppl 3:s404-s411; http://www.medigraphi.com/pdfs/salpubmex/sal-2007/sals0731.pdf; http://dx.doi.org/10.1590/S0036-36342007000900012
   Google Scholar
• Navarrete NS, Alvarez MMT, Bustamante CME, Vallejo AOJ, Muñoz O, Santos JI, Ávila FC. Protection of health personnel against hepatitis B by DNA recombinant vaccine. Bol Med Hosp Infant Mex 1992; 49(11):739-42; PMID:1466772
   PubMedGoogle Scholar
• López OAR, González GA, Hernández DB, Meneses RCD, León AG, Trejo JJ. Manual de procedimientos técnicos de vacunación actualización. México, DF. Secretaría de Salud 2003; www.conicenciaradio.com/DOCSAL7301.pdf
   Google Scholar
• López CVLR, González GA, Coronel MDL, Aldama CO, Gómez ACM, Linares DJF, et al. Manual de Vacunación 2008-2009. Secretaría de Salud 2008; salud.chiapas.gob.mx/doc/biblioteca_virtual/manuales-modelos/manual_va
   Google Scholar
• Barrera CA, Castañeda DAG, Montaño LA, Peralta JR, Serna OJS. Guía de práctica clínica: Diagnóstico y tratamiento de la infección crónica por virus de hepatitis B. Centro Nacional de Excelencia Tecnológica en Salud; Secretaria de Salud 2009; http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/419_GPC_Diagnostico_tratamiento_HEPATITIS_POR_VIRUS_B/GPC-Hepatitis_B.pdfcurfile format pdf
   Google Scholar
• Santos JI. El Programa Nacional de Vacunación: Orgullo de México. Rev Fac Med UNAM 2002; 45(3):142-153; www.medigraphi.com/pdf/facmed/un2002/un23g.pdf
   Google Scholar
• Flores SL, Paredes SS, Balanzar MA, Flores MM, Legorreta SJ, Andersson N. Hepatitis B vaccination coverage and associated factor for vaccine acceptance: a cross-sectional study in health workers of the Acapulco General Hospital, Mexico. Gac Med Mex 2014; 150(5):395-402; PMID:25275841
   PubMed Web of Science ®Google Scholar
• von Lindeman K, Kugler J, Klewer J. Vaccinations among students in health care professions. Pflege Z 2011; 64(12):740-3; PMID:22242368
   PubMedGoogle Scholar
• Faure E, Cortot C, Gosset D, Cordonnier A, Deruelle P, Guery B. Vaccine status of healthcare students in Lille. Med Mal Infect 2013; 43(3):114-7; PMID:23498136; http://dx.doi.org/10.1016/j.medmal.2013.02.002
   PubMed Web of Science ®Google Scholar
• Loulergue P, Pulcini C, Massin S, Bernhard M, Fonteneau L, Levy BD, Guthmann JP, Launay O. Validity of self-reported vaccination status among French healthcare students. Clin Microbiol Infect 2014; 20(12):O1152-4; PMID:25040583; http://dx.doi.org/10.1111/1469-0691.12759
   PubMedGoogle Scholar
• Oliveira LC, Pontes JP. Frequency of hepatitis B immunity and occupational exposures to body fluids among Brazilian medical students at a public university. Rev Inst Med Trop Sao Paulo 2010; 52(5):247-52; PMID:21049228; http://dx.doi.org/10.1590/S0036-46652010000500005
   PubMed Web of Science ®Google Scholar
• Carvalho P, Schinoni MI, Andrade J, Vasconcelos RMA, Marques P, Meyer R, Araújo A, Menezes T, Oliviera C, Macedo RS, et al. Hepatitis B virus prevalence and vaccination response in health care workers and students at the Federal University of Bahia, Brazil. Ann Hepatol 2012; 11(3):330-7; PMID:22481451
   PubMed Web of Science ®Google Scholar
• Pathoumthong K, Khampanisong P, Quet F, Latthaphasavang V, Souvong V, Buisson Y. Vaccination status, knowledge and awareness towards hepatitis B among students of health professions in Vientiane, Lao PDR. Vaccine 2014; 32(39):4993-9: PMID:25066734; http://dx.doi.org/10.1016/j.vaccine.2014.07.022
   PubMed Web of Science ®Google Scholar
• Momeni N, Ahmad AMS, Alavian SM, Shamshiri AR, Norouzi M, Mahboobi N, Moosavi N, Jazayeri SM. HBV vaccination status and response to hepatitis B vaccine among Iranian dentists, correlation with risk factors and preventive measures. Hepat Mon 2014; 15(1):e20014; PMID:25741367
   PubMedGoogle Scholar
• Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis 1999; 179(2):489-92; PMID:9878036; http://dx.doi.org/10.1086/314578
   PubMed Web of Science ®Google Scholar
• Coates T, Wilson R, Patrick G, Andre F, Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 2001; 23(3):392-403; PMID:11318074; http://dx.doi.org/10.1016/S0149-2918(01)80044-8
   PubMed Web of Science ®Google Scholar
• Schillie S, Murphy TV, Sawyer M, Ly K, Hughes E, Jiles R, de Perio MA, Reilly M, Byrd K, Ward JW. Center for Disease Control and Prevention. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 2013; 62(RR-10):1-19; PMID:24352112
   PubMed Web of Science ®Google Scholar
• Norouzirad R, Shakurrnia AH, Assarehzadegen MA, Serajian A, Khabazkhoob M. Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to18 years in Ahvaz city southwest of Iran. Hep Mon 2014; 14(1):e13625; PMID:24497878
   PubMedGoogle Scholar
• Chinchai T, Chirathaworn C, Praianantathavorn K, Theamboonlers A, Hutagalung Y, Bock PH, Thantiworasi P, Poovorawan Y. Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization. Viral Immunol 2009; 22(2):125-30; PMID:19326999; http://dx.doi.org/10.1089/vim.2008.0087
   PubMed Web of Science ®Google Scholar
• Bautista AH, Castellanos DYZ, Farfán AE. Marcadores serológicos y moleculares de infección por el virus de la hepatitis B en estudiantes universitarios colombianos. Rev Colomb Gastroenterol 2012; 27:282-90; [email protected];
   Google Scholar
• Su FH, Chen JD, Cheng SH, Lin CH, Liu YH, Chu FY. Seroprevalence of hepatitis B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program. J Med Virol 2007; 79(2):138-43; PMID:17177303; http://dx.doi.org/10.1002/jmv.20771
   PubMed Web of Science ®Google Scholar
• Juarez FLA, Uribe UFJ, Conde GCJ, Sánchez AMA. Serological markers of hepatitis B and C, and HIV in La Calera and Cuambio, Guerrero, Mexico. Salud Publica Mex 2011; 53suppl 1:S32-6; PMID:21877071
   PubMedGoogle Scholar
• Panduro A, Escobedo MG, Fierro NA, Ruiz MB, ZepedaC EA, Roman S. Epidemiology of viral hepatitis in Mexico. Salud Publica Mex 2011; 53 suppl 1:S37-45; PMID:21877071
   PubMedGoogle Scholar
• Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Transfusion 2012; 52(2):440-6; PMID:21810101; http://dx.doi.org/10.1111/j.1537-2995.2011.03283.x
   PubMed Web of Science ®Google Scholar
• Kiely P, Margaritis AR, Seed CR, Yang H. Australian Cross Blood Service NAT Study Group. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Transfusion 2014; 54(8):2084-91; PMID:24650170; http://dx.doi.org/10.1111/trf.12556
   PubMed Web of Science ®Google Scholar
• Roman S, Panduro A, Aguilar GY, Maldonado M, Vázquez VM, Martínez LE, Ruiz MB, Hernández NZ. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol Int 2009; 3(2):343-55; PMID:19669360; http://dx.doi.org/10.1007/s12072-008-9115-9
   PubMed Web of Science ®Google Scholar
• Hernández SR, Fernández CC, Baptista LP. Metodología de la Investigación. Ed McGraw Hill/Interamericana Mexico D.F.; 4ta edición 2010; p 244-247; ISBN 10: 970 10 5753 8
   Google Scholar